Themed "Global IVD Innovation & Cross-Regional Integration," this groundbreaking event brings together distinguished experts from around the world to explore the future of diagnostics.

Quest Diagnostics said Wednesday that it has internally developed a test for monkeypox and launched it, while it also plans to begin offering the US Centers for Disease Control and Prevention's monkeypox test next month.

In 2021, the total number of visits to medical and health institutions in nationwide was 8.47 billion, a year-on-year increase of 9.4%. The average citizen visits medical and health institutions 6 times a year.

Merck, known as MSD outside the United States and Canada, now offers the Merck Digital Sciences Studio, designed to enable innovative tech for drug discovery and development.

Twist Bioscience and DNAnexus said on Wednesday that they are collaborating on data analysis to help customers develop next-generation sequencing-based diagnostics.

Recently, Hotgen Coronavirus (2019-nCoV)-Antigentest has officially passed 3a validation of the UK Department of Health and Social Care (DHSC), which proves that the antigen test not only has high specificity, but also has high detection sensitivity.

UK-based startup Tailor Bio has received ￡650,000 ($771,767) through the Innovate UK Biomedical Catalyst Award in support of its ambitions to develop a pan-cancer precision medicine platform.

The National Comprehensive Cancer Network on Tuesday published new guidelines for treating children with brain cancer, underscoring the importance of broad molecular profiling in diagnosing, treating, and identifying clinical trial opportunities for patients.

Recently, Shanghai University, relying on Shanghai's scientific and educational resources, gave full play to the cross-integration of multiple disciplines such as machinery and control, and the national first-class discipline of "mechanical engineering"

Biomarker discovery firm Sapient said Monday that it has received a $9.2 million grant from the Bill & Melinda Gates Foundation for mass spectrometry-based metabolomic biomarker studies.

Hologic and Thermo Fisher Scientific announced separately on Monday that they have received CE-IVD marking for their respective RT-PCR-based respiratory virus assays.